An internal document from Heineken shows increasing corporate concern regarding the expanding adoption of weight-loss drugs. The brewer is assessing how these pharmaceuticals could dampen beverage alcohol consumption patterns globally.
Read the full report at Hospitality Ireland
Summary written by Distillers Hub from the original report. Spotted an error? Tell us.